Article

Cutaneous T-Cell Lymphoma in a Patient With Neurofibromatosis Type 1

Cutis. 2003 July;72(1):27-30

PDF Download

References

Hager CM, Cohen PR, Tschen JA. Segmental neurofibromatosis: case reports and review. J Am Acad Dermatol. 1997;37:864-869.
Zvulunov A, Esterly NR. Neurocutaneous syndromes associated with pigmentary skin lesions. J Am Acad Dermatol. 1995;32:915-935.
Hope DG, Mulvihill JJ. Malignancies in neurofibromatosis. Adv Neurol. 1981;29:33-56.
Eichenfield LF, Levy ML, Paller AS, et al. Guidelines of care for neurofibromatosis type 1. J Am Acad Dermatol. 1997;37:625-630.
Trattner A, David M, Ingber A, et al. Coexistence of late-onset neurofibromatosis and cutaneous T cell lymphoma. J Am Acad Dermatol. 1990;23:932-934.
Mulvihill JJ, Parry DM, Sherman JL, et al. NIH conference. neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis): an update. Ann Intern Med. 1990;113:39-52.
Leroy K, Dumas V, Martin-Garcia N, et al. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Arch Dermatol. 2001;137:908-913.
Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981;305:1617-1627.
Olsen EA, Delzell E, Jegasothy BV. Second malignancies in cutaneous T cell lymphoma. J Am Acad Dermatol. 1984;10:197-204.
Knight WA III, Murphy WK, Gottlieb JA. Neurofibromatosis associated with malignant neurofibromas. Arch Dermatol. 1973;107:747-750.
Mastrangelo MF, Goepp CE, Patel YA, et al. Cutaneous melanoma in a patient with neurofibromatosis. Arch Dermatol. 1979;115:864-865.
Wu H, Elenitsas R. Malignant nodular hidradenoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Cutis. 2001;68:273-278.
Otsuka F, Kawashima T, Imakado S. Lisch nodules and skin manifestations in neurofibromatosis type 1. Arch Dermatol. 2001;137:232-233.
Duvic M. Treatment of cutaneous T-cell lymphoma from a dermatologist's perspective. Clin Lymphoma. 2000;1:515-520.
Kantor AF, Curtis RE, Vonderheid EC, et al. Risk of secondary malignancy after cutaneous T-cell lymphoma. Cancer. 1989;63:1612-1615.

Cutaneous T-Cell Lymphoma in a Patient With Neurofibromatosis Type 1

References

Pages

Recommended Reading